Citadel Advisors - PETROS PHARMACEUTICALS INC ownership

PETROS PHARMACEUTICALS INC's ticker is PTPI and the CUSIP is 71678J100. A total of 22 filers reported holding PETROS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PETROS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$136,000
+61.9%
265,920
+161.7%
0.00%
Q2 2022$84,000
-62.7%
101,606
-29.6%
0.00%
Q1 2022$225,000
+122.8%
144,270
+377.7%
0.00%
Q4 2021$101,000
+381.0%
30,200
+191.3%
0.00%
Q3 2021$21,000
-80.9%
10,367
-70.4%
0.00%
Q2 2021$110,000
-16.0%
35,062
-1.2%
0.00%
Q1 2021$131,00035,4920.00%
Other shareholders
PETROS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
CM Management, LLC 100,000$313,0000.23%
Shay Capital LLC 238,764$747,0000.09%
EMFO, LLC 28,000$88,0000.08%
Platform Technology Partners 44,000$138,0000.06%
NorthRock Partners, LLC 219,188$686,0000.06%
ACORN FINANCIAL ADVISORY SERVICES INC /ADV 50,200$157,0000.05%
NEVILLE RODIE & SHAW INC 21,875$68,0000.01%
Virtu Financial LLC 14,364$45,0000.00%
Newbridge Financial Services Group, Inc. 1,200$4,0000.00%
BANK OF AMERICA CORP /DE/ 34$00.00%
View complete list of PETROS PHARMACEUTICALS INC shareholders